Fibralign Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Fibralign General Information

Description

Developer of advanced therapeutic biomedical devices designed to target unmet needs in regenerative medicine. The company's biomedical device, BioBridge, uses scaffolding technology that mimics human tissue structure, directly influences cell behavior and orientates collagen fibers, enabling professionals to help in the body's regenerative repair and maintenance process.

Contact Information

Website
www.fibralignbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 32930 Alvarado-Niles Road
  • Suite 350
  • Union City, CA 94587
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences
Corporate Office
  • 32930 Alvarado-Niles Road
  • Suite 350
  • Union City, CA 94587
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fibralign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC Completed Generating Revenue
9. Grant 01-Jan-2018 Completed Generating Revenue
8. Angel (individual) 27-Nov-2017 Completed Generating Revenue
7. Grant 15-Apr-2016 Completed Startup
6. Grant 01-Jan-2016 Completed Startup
5. Accelerator/Incubator 19-Jun-2014 Completed Startup
4. Grant 19-Jun-2014 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Jun-2014 Completed Startup
1. Angel (individual) Completed Startup
To view Fibralign’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Fibralign Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 42

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Fibralign Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240149035-A1 Conductive biocompatible scaffold for electroporation Pending 01-Mar-2021
US-20180214575-A1 Composition for targeted delivery of nucleic acid-based therapeutics Pending 24-Jul-2015
JP-2021185153-A Compositions for targeted delivery of nucleic acid based therapeutics Pending 24-Jul-2015
JP-2018521084-A Compositions for targeted delivery of nucleic acid based therapeutics Pending 24-Jul-2015
US-20160256605-A1 Method and device for lymphedema treatment Active 10-Oct-2013 A61K38/18
To view Fibralign’s complete patent history, request access »

Fibralign Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fibralign Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
AngelMD Angel Group Minority
BioSciKin Corporation
National Science Foundation Government
United States Department of Defense Government
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Fibralign FAQs

  • When was Fibralign founded?

    Fibralign was founded in 2007.

  • Where is Fibralign headquartered?

    Fibralign is headquartered in Union City, CA.

  • What is the size of Fibralign?

    Fibralign has 11 total employees.

  • What industry is Fibralign in?

    Fibralign’s primary industry is Biotechnology.

  • Is Fibralign a private or public company?

    Fibralign is a Private company.

  • What is Fibralign’s current revenue?

    The current revenue for Fibralign is .

  • Who are Fibralign’s investors?

    U.S. Department of Health and Human Services, AngelMD, BioSciKin, National Science Foundation, and United States Department of Defense are 5 of 10 investors who have invested in Fibralign.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »